Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Sock, This
http://www.femgj.com/cpzx/gnbj/show-103.html
and others would suggest the don't have total exclusivity in China
Hi sphinx100 - Okay. I see ehaf h mean.
Hi davidxie77 - Just out of interest, on the By health website (UK site), I counted 69 products. So, in terms of there being 200 products, are only 69 available online, and the rest u have to buy in shops? Or, is it that only 69 are available on the UK site?
They're not , but it just emphasises the process and cost .
...sorry, am I missing something, when and where was PHDS referred to by Provexis?
PHDS in Dietary Supplement Registration
PHDS enjoys a high reputation and widespread acclaim for successful registration experience in China for over 25 years for health food, dietary supplement, food ingredients and GRAS products. PHDS provides high quality, high efficiency and reliable service of regulatory consulting and registration for clients from over 54 countries. As an expert in regulatory affairs in China, PHDS possesses enormous successful registration experience for health food.
The regulatory management of China's dietary supplement industry has always been a controversial issue especially over the pasted years. CFDA requires companies to apply for a registration before marketing. The registration is referred to as a "blue hat" registration because the logo resembles a blue hat. Most registration could cost upwards of $100,000 or more per product depending on what claim is being made and what the ingredients are, then various laboratory tests and animal tests would be taken. Since the issue of Health Food Registration and Filing Management Procedure, the products that meet the requirements of specific ingredients and usage can go throug a filing procedure, which is called a "orange hat". PHDS as a leading professional expert in such regulatory affairs has a very high efficient and high successful rate for the registration with CFDA.
PHDS gets your products into China faster.
Perhaps By-health have exclusively in China. You'd think that if By-health are going to pay for trials etc, and marketing, that would be in the arrangement. But, there are other countries / continents. I realise there's no evidence to back up this, however.
Wow...u said it, davidxie77! Great to hear from u!
one more thing to add, Byhealth is not the only client we have. If Fruitflow is promoted heavily by such a giant, more companies will jump on the Fruitflow wagon.
blue hat normally takes 3 years to be granted, each submission cost 60k to 100k (over 500k on some cases) By health currently have around 200 sku and 140 are blue hatted, they are definitely the know how company in terms of getting the blue hat status. My guess is that 2 years will be sufficient for them to put a blue hat on Fruitflow products, hence Q1 next year we should see some significant progresses.
The turnover of By health last year was 5.2B RMB (£580 MILLION) with gross margin of 67%, 200 SKU will give each products £2.9M of annual sales, if Byhealth launch 8 products containing Fruitflow, they are paying 8*2.9*0.33=£7.66 m to DSM, if the profit share between DSM and PXS is 70/30, revenue for PXS will be £2.3 m(Multiple of current sales of 450k), PXS gross profit margin was 90% (according to audited account ended 30 Sep 2019), £2.3m *0.9- 800k(R&D, Admin and distribution cost)= £1.3M in profit, work on the PE of 30, our market cap should be £39M while the current Market cap is £14M. So when people saying we are heading towards 0.35p, please advise your thoughts behind that.
I hold a few millions of shares in PXS and am willing to wait for another 10 years as i think Fruitflow will benefit millions of people, in fact i have more faith in PXS than the 3 companies i am running at the moment :)
T
June rise was due to a major shareholder increasing his stake.
No attempt to spin it negatively is credible.
When someone takes a percentage out of the market, and doesn't sell them, the sp reacts.
Seen you in too many guises over the years. Learn the lesson of history, vanish and re-invent yourself again in the future.
You know you will.
Sorry ever hopeful ,just to be clear ,you are saying if the Chinese don't launch a blue cap product then the share price will drop below and if they launch a blue cap product will wull have and increase in the sp( i hope it is successful)
Apologies if already posted. I just don't remember it being completely available when (I think) gixer posted it previously.
Aspirin & FF trial might be because of Aspirin resistance. Taking FF with it should help.
http://www.wjtcm.net/article.asp?issn=2311-8571;year=2019;volume=5;issue=4;spage=260;epage=268;aulast=Zhang
for 18 months we have had higher lows if it breaks 0.4 p ish then that trend may be under threat . If the Chinese are going to launch a SP changing product then they'd of had a plan in Re to buying shares I guess , if that is happening then they are being very stealthy.
https://www.provexis.org/shareholder-information/major-shareholders/
So you believe this will drop to 0.42
June rise to 1p was a clever P&D as I speculated at the time , trend line to watch is at 0.425 p approx .
https://www.tradingview.com/x/DXyiGwSp/
The Chinese have not yet launched anything major , if they do then it will be great .I imagine out there you'd have to spend £25 mill on advertising to launch a Nationwide health product.
You claimed that the rise was based on nothing. Clearly not true.
Will any holder of a significant amount sell on the basis of having to wait for the Blue Hat process to complete. knowing that the$4 billion By Health have funded the scientific work needed?
Your claim of utter certainty that you know where the sp will go is fake. As are you.
For a so called doctor, you seem to find telling lies very easy.
Mr Lucas increased his stake by many millions of shares. How can you even think of claiming there was nothing behind the rise?
Personally I find it disgusting that fake ID's are invented to try to ruin value for genuine holders. Neither you or Naz are anything other than fakes IMHO. Created in order to try to manipulate the sp down.
I am a surprised about the dropp in the sp ,In the past 3 weeks this share has dropped.,Could it be due to the rising tensions between America and China as the index are dropping on both sides
Good question Yesman but nobody knows.
From the December '18 interim results... I think this is the most recent...
'The two completed studies (a human study and an animal study) showed excellent results in use for Fruitflow®, and BY-HEALTH intends to make its first blue cap submission to the SAMR for Fruitflow® in February 2019, with a further blue cap submission envisaged later in 2019, both to include references to the Company's existing European Food Safety Authority ('EFSA') health claim for Fruitflow'.
Guys when is this blue hat approval expected in China, is it by end of this year?
Thanks
I suspect By-health are happy to pay for all the studies. I think Chinese philosophy in particular is to see things long term. A bit of money now for studies, and then reep the substantial rewards later on. I imagine that By-health will also learn a lot in terms of how to conduct trials given Provexis is very good in that area. I was watching a video the other day about China spending a lot of money building roads in an African country (I forget which one) and they didn't want anything in return. The purpose was to generate goodwill and show off what China can do, and later on down the line it is hoped it will lead to substantial economic projects / rerurns. Anyway, I know this is all speculation, but I wanted to get my thoughts out.
The statement is pretty vague and gives us no idea to what is involved in the "projects".
Yes By-Health is contributing financially to this but I would assume if they were to take any project work further then they would be doing studies themselves in China as we have been told that this is a requirement for Blue Cap.
We will still own the intellectual property but I doubt By Health would finance our trials or EFSA approvals.
Hi gixer,
I think all the studies are to be financed by By-health. As per the December RNS;
'...with all projects envisaged to be at By-Health's sole expense'.
'Projects conducted under the agreement will be focussed on specific areas of commercial focus for By-Health, and the first project which has been agreed will concentrate on the use of Fruitflow with nitrates in exercise, an area of considerable commercial interest to By-Health in China.'
Sock